Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and eicosapentaenoic acid ethyl ester

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with eicosapentaenoic acid ethyl ester in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(eicosapentaenoic acid ethyl ester)
Trials
(eicosapentaenoic acid ethyl ester)
Recent Studies (post-2010) (eicosapentaenoic acid ethyl ester)
9,15618755242199262

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akkerman, JW; Banga, JD; de Graaf, JC; Erkelens, DW; Sixma, JJ; van Breugel, HH; Westerveld, HT1
Hata, N; Kobayashi, T; Misawa, Y; Ohhashi, K; Okuyama, H; Takahashi, T; Watanabe, S1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and eicosapentaenoic acid ethyl ester

ArticleYear
Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.
    Diabetes care, 1993, Volume: 16, Issue:5

    Topics: Adenosine Diphosphate; Analysis of Variance; Blood Glucose; Blood Platelets; Blood Viscosity; Collagen; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Eicosapentaenoic Acid; Endothelium, Vascular; Erythrocyte Deformability; Extracellular Matrix; Female; Humans; In Vitro Techniques; Lipoprotein(a); Male; Middle Aged; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation

1993

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and eicosapentaenoic acid ethyl ester

ArticleYear
Effect of replacing a high linoleate oil with a low linoleate, high alpha-linolenate oil, as compared with supplementing EPA or DHA, on reducing lipid mediator production in rat polymorphonuclear leukocytes.
    Biological & pharmaceutical bulletin, 1998, Volume: 21, Issue:6

    Topics: alpha-Linolenic Acid; Animals; Calcimycin; Dietary Fats, Unsaturated; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Ionophores; Linoleic Acid; Male; Neutrophils; Phospholipids; Plant Oils; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Safflower Oil

1998